Advanced company searchLink opens in new window

ARGENT BIOPHARMA (UK) LTD

Company number 09750155

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Oct 2024 AD02 Register inspection address has been changed from C/O Pkf Littlejohn 15 Westferry Circus Canary Wharf London E14 4HD United Kingdom to 3rd Floor, Great Titchfield House 14-18 Great Titchfield Street London W1W 8BD
22 Oct 2024 CS01 Confirmation statement made on 25 August 2024 with updates
22 Oct 2024 CH01 Director's details changed for Mr Anthony Neville Chisholm Eastman on 22 October 2024
21 Oct 2024 AD01 Registered office address changed from 25 Eccleston Place Eccleston Yards London SW1W 9NF England to 3rd Floor, Great Titchfield House 14-18 Great Titchfield Street London W1W 8BD on 21 October 2024
21 Oct 2024 PSC05 Change of details for Mgc Pharmaceuticals Ltd as a person with significant control on 18 March 2024
20 Apr 2024 AA Full accounts made up to 30 June 2023
12 Apr 2024 CERTNM Company name changed mgc pharma (uk) LTD\certificate issued on 12/04/24
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2024-04-01
19 Jan 2024 AD01 Registered office address changed from C/- Central Working Ecclestone Yards 25 Ecclestone Place London SW1W 9NF United Kingdom to 25 Eccleston Place Eccleston Yards London SW1W 9NF on 19 January 2024
23 Sep 2023 AA Full accounts made up to 30 June 2022
19 Sep 2023 DISS40 Compulsory strike-off action has been discontinued
18 Sep 2023 CS01 Confirmation statement made on 25 August 2023 with no updates
05 Sep 2023 GAZ1 First Gazette notice for compulsory strike-off
07 Jun 2023 TM01 Termination of appointment of Brett Anthony Mitchell as a director on 1 June 2023
29 Sep 2022 CS01 Confirmation statement made on 25 August 2022 with no updates
29 Sep 2022 PSC02 Notification of Mgc Pharmaceuticals Ltd as a person with significant control on 9 February 2021
29 Sep 2022 PSC09 Withdrawal of a person with significant control statement on 29 September 2022
08 Jun 2022 DISS40 Compulsory strike-off action has been discontinued
07 Jun 2022 AA Full accounts made up to 30 June 2021
31 May 2022 GAZ1 First Gazette notice for compulsory strike-off
30 Sep 2021 CS01 Confirmation statement made on 25 August 2021 with no updates
16 Jul 2021 AA Full accounts made up to 30 June 2020
18 Sep 2020 TM01 Termination of appointment of Nativ Segev as a director on 31 August 2020
14 Sep 2020 CS01 Confirmation statement made on 25 August 2020 with no updates
14 Sep 2020 CH01 Director's details changed for Mr Anthony Neville Chisholm Eastman on 2 September 2019
26 Aug 2020 AA Full accounts made up to 30 June 2019